Private Equity
Rewire said it raised $12 million of Series A capital in a round led by Viola Fintech and joined by BNP Paribas' investment arm Opera Tech Ventures, OurCrowd, Moneta, Yair Tauman, Yaron Lemelbaum, Leon Vaidman and Standard Bank of South Africa.
1 min read · 26 March 2019
SentiLink said it raised $14 million of Series A capital in a deal led by Andreessen Horowitz and joined by Nyca Partners, Goldcrest, Felicis Ventures, Caffeinated Capital, Max Levchin and Zach Perret.
1 min read · 26 March 2019
Las Olas Venture Capital said March 26 that it invested in Preteckt. Financial terms weren’t announced. Preteckt provides vehicle prognostics as a service to connected and autonomous vehicle manufacturers and service providers.
2 min read · 26 March 2019
Airwallex said March 25 that it raised $100 million in Series C finding led by DST Global. Existing investors Sequoia Capital China, Tencent, Hillhouse Capital, Gobi Partners, Horizons Ventures and Square Peg Capital participated in the round. Airwallex provides cross border payments.
3 min read · 26 March 2019
District Ventures Capital said March 26 that it invested in OHi Food Co. Financial terms weren’t announced. OHi Food produces the refrigerated OHi Superfood Bar.
3 min read · 26 March 2019
Lola.com said March 26 that it raised $37 million in Series C funding led by led by existing investors General Catalyst and Accel. Also participating were previous investors CRV, Tenaya Capital and GV. Lola.com, of Boston, provides travel management software.
4 min read · 26 March 2019
1 min read · 26 March 2019
South Park Commons has raised $52.2 million toward a maiden venture-capital fund, according to a filing with the SEC.
1 min read · 25 March 2019
Cybex said March 25 that it raised $18 million in funding led by Qualcomm Ventures LLC and Inven Capital. Existing investors Norwest Venture Partners, Glilot Capital Partners, Flint Capital, and OurCrowd also participated in the round. Cybex, of Boston, is an industrial cybersecurity company.
5 min read · 25 March 2019
Thermo Fisher Scientific Inc said March 24 that it is buying Brammer Bio for approximately $1.7 billion in cash. Ampersand Capital Partners is the seller. Brammer Bio is a viral vector contract development and manufacturing organization.
5 min read · 25 March 2019